Mobile Menu

Search Results

Search results for: open innovation

Crowdsourcing and open innovation in drug discovery

In the past decade, there has been a significant growth in the use of crowdsourcing and open innovation approaches to […]

IBM Watson teams up with Anaconda to simplify AI open- source adoption

Image source: AiTHORITY IBM Watson has announced a new collaboration with leading Python data science platform provider, Anaconda, Inc., to […]

Interview with Dr Rona Strawbridge, UKRI Innovation

Dr Rona Strawbridge has been using genetics to try to understand complex diseases, who’s work has focused much on obesity, type 2 diabetes and cardiovascular disease, and more recently serious mental illness. We managed to have a chat with Rona ahead of her speaking at the Festival of Genomics about her work and why she’s excited to be speaking at the festival this year.

Digitising Pharma R&D: A webinar series

The pharmaceutical industry is undergoing a digital revolution. Now armed with more data than ever before, novel discoveries are just […]

Digitising Pharma R&D: Webinar series

The pharmaceutical industry is undergoing a digital revolution. Now armed with more data than ever before, novel discoveries are just […]

Interview with Anandbir Brar, Chief Executive Officer, Excelra

We recently interviewed Anandbir Brar, Chief Executive Officer of Excelra. Excelra is the lead sponsor for our D4 Global virtual event.  […]

Powering drug discovery with 10 simple rules

A recent Perspective, published in PLOS Computational Biology, has highlighted 10 simple rules to power drug discovery with data science. […]

Pistoia Alliance and CAS partner for chemical safety library

The Pistoia Alliance has partnered with CAS, a division of the American Chemical Society specialising in scientific information solutions, to […]

Silq: The first intuitive quantum computing language

Computer scientists at ETH Zurich have designed a new programming language that, they say, will make programming quantum computers as […]

Opinion: Can big pharma and public health be compatible?

Since nearly as long as we’ve enjoyed the company of SARS-Cov-2, we’ve heard the cynics and sceptics among us forecast […]